Morana Jovan-Embiricos's Net Worth

-$40.8 Million

Estimate Recalculated Jun 27, 2024 06:02PM EST

Who is Morana Jovan-Embiricos?

Morana Jovan-Embiricos does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cullinan Oncology, Inc., Radius Health, Inc., Allovir, Inc., and TCR2 THERAPEUTICS INC..

SEC CIK

Morana Jovan-Embiricos's CIK is 0001575745

Past Insider Trading and Trends

2021 was Morana Jovan-Embiricos's most active year for acquiring shares with 13 total transactions. Morana Jovan-Embiricos's most active month to acquire stocks was the month of January. 2019 was Morana Jovan-Embiricos's most active year for disposing of shares, totalling 48 transactions. Morana Jovan-Embiricos's most active month to dispose stocks was the month of November. 2020 saw Morana Jovan-Embiricos paying a total of $49,300,000.00 for 18,401,898 shares, this is the most they've acquired in one year. In 2019 Morana Jovan-Embiricos cashed out on 19,324,232 shares for a total of $12,965,386.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cullinan Oncology, Inc. (CGEM) Snapshot price: $18.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.82%
-49.91K
$14.26
-$711,676.33
1.26M
Aug 2 - Aug 4
Form 4
+84.70%
95.3K
$8.85
$13.78
207.8K
Jun 24
Form 4
-15.94%
-101.90K
$12.80
-$1,304,816.42
537.39K
Jun 21 - Jun 23
Form 4
-24.28%
-418.74K
$9.66
-$4,045,791.27
1.31M
May 12 - May 16
Form 4
—
0
—
—
0
Sep 16
Form 4
-40.78%
-1.19M
—
—
1.72M
Jan 11
Form 4
+517.59%
6.03M
$21.00
$4,200,000.00
7.19M
Jan 12
Form 3
—
0
—
—
0
No matching records found

Radius Health, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jan 8
Form 4
-100.00%
-587.50K
—
—
0
Jul 10 - Jul 15
Form 4
-25.00%
-389.33K
—
—
1.17M
Jan 8
Form 4
—
0
—
—
0
Dec 17
Form 4
∞
3.25M
$8.00
$4,700,000.00
3.25M
Jun 11
Form 4
∞
1.56M
—
—
1.56M
Jun 6
Form 4
—
0
—
—
0
Feb 14
Form 3
—
0
—
—
0
No matching records found

Allovir, Inc. (ALVR) Snapshot price: $0.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+53.68%
35K
—
—
100.2K
Jun 6
Form 4
+115.91%
35K
—
—
65.2K
May 11
Form 4
+44.42%
8.15M
$4.61
$37,581,858.67
26.5M
Jul 28
Form 4
—
0
—
—
0
May 17
Form 4
-0.05%
-800.00
$24.77
-$19,812.00
1.72M
Scheduled
Nov 10
Form 4
-0.70%
-12.20K
$24.80
-$302,455.18
1.72M
Scheduled
Nov 5 - Nov 9
Form 4
-0.13%
-2.20K
$24.78
-$54,510.49
1.73M
Scheduled
Oct 27
Form 4
-0.78%
-13.59K
$24.80
-$337,045.36
1.73M
Scheduled
Oct 21 - Oct 25
Form 4
—
0
—
—
0
May 25
Form 4
+7,440.72%
18.38M
$17.00
$49,300,000.00
18.63M
Aug 3
Form 4
—
0
—
—
0
Jul 29
Form 3
—
0
—
—
0
No matching records found

TCR2 THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-31.63%
-644.86K
$16.74
-$740,386.65
1.39M
Dec 18 - Dec 20
Form 4
-2.71%
-204.56K
$17.64
-$3,609,169.58
7.34M
Dec 9 - Dec 11
Form 4
-0.15%
-3.89K
$15.16
-$58,930.80
2.55M
Oct 22
Form 4
-6.69%
-416.32K
$17.63
-$7,459,819.36
5.81M
Sep 20 - Sep 23
Form 4
-38.46%
-64.10K
$17.11
-$1,097,079.79
102.56K
Aug 21 - Sep 4
Form 4
+520.46%
3.57M
$15.00
$10,000,005.00
4.26M
Feb 19
Form 3
—
0
—
—
0
No matching records found